SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-030594
Filing Date
2020-02-11
Accepted
2020-02-11 07:07:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d859853dsc13ga.htm SC 13G/A 37269
  Complete submission text file 0001193125-20-030594.txt   39096
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47575 | Film No.: 20593886
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences

Mailing Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001
Business Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001 41-44-234-1111
UBS Group AG (Filed by) CIK: 0001610520 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
Office of Finance